Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Healthcare Diagnostics & Research
Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Avricore Health Inc
Bullboard Posts
User Avatar Image
(0)
•••
Post by Wolverine7294on May 22, 2016 6:55pm
108 Views
Post# 24896690

Saskatchewan Drug Formulary Part #2

Saskatchewan Drug Formulary Part #2
  Class Generic Name Strength/Form Brand Name DIN MFR Unit Price Interchangeable SOC EDS
  28:16:04 CITALOPRAM HYDROBROMIDE 40MG TABLET VAN-CITALOPRAM 02438755 VAN $0.2397 Y    
  28:16:04 FLUOXETINE 10MG CAPSULE VAN-FLUOXETINE 02432412 VAN $0.4595 Y    
  28:16:04 FLUOXETINE 20MG CAPSULE VAN-FLUOXETINE 02432420 VAN $0.4598 Y    
  28:16:04 SERTRALINE HYDROCHLORIDE 25MG CAPSULE VAN-SERTRALINE 02427761 VAN $0.2004 Y    
  28:16:04 SERTRALINE HYDROCHLORIDE 50MG CAPSULE VAN-SERTRALINE 02427788 VAN $0.4000 Y    
  28:16:04 SERTRALINE HYDROCHLORIDE 100MG CAPSULE VAN-SERTRALINE 02427796 VAN $0.4200 Y    
  56:40:00 OMEPRAZOLE (MAC) 20MG CAPSULE/TABLET VAN-OMEPRAZOLE 02432404 VAN $0.4117 Y    
  56:40:00 PANTOPRAZOLE SODIUM 40MG ENTERIC COATED TABLET VAN-PANTOPRAZOLE 02428164 VAN $0.3628 Y    
  68:20:28 PIOGLITAZONE HCL 15MG TABLET VAN-PIOGLITAZONE (EDS) 02434121 VAN $0.6225 Y   EDS
  68:20:28 PIOGLITAZONE HCL 30MG TABLET VAN-PIOGLITAZONE (EDS) 02434148 VAN $0.8721 Y   EDS
  68:20:28 PIOGLITAZONE HCL 45MG TABLET VAN-PIOGLITAZONE (EDS) 02434156 VAN $1.3113 Y   EDS
  92:00:00 ALENDRONATE SODIUM 10MG TABLET VAN-ALENDRONATE (EDS) 02428725 VAN $0.4987 Y   EDS
  92:00:00 ALENDRONATE SODIUM 70MG TABLET VAN-ALENDRONATE (EDS) 02428733 VAN $2.5144 Y   EDS
  92:00:00 FINASTERIDE 5MG TABLET VAN-FINASTERIDE 02428741 VAN $0.4633 Y    
  92:00:00 MYCOPHENOLATE MOFETIL 250MG CAPSULE VAN-MYCOPHENOLATE (EDS) 02433680 VAN $0.5155 Y   EDS
  92:00:00 MYCOPHENOLATE MOFETIL 500MG TABLET VAN-MYCOPHENOLATE (EDS) 02432625 VAN $1.0310 Y  

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities